Zhou Zhu-ren, Sun Kai-lai
Department of Medical Genetics, China Medical University, Shenyang, Liaoning, 110001 P.R.China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Apr;23(2):177-80.
Alternative splicing of pre-mRNA is an important mechanism for regulating gene function at the post-transcription level and for producing proteomic diversity in higher eukaryotes. The alternative splicing is regulated by the interaction between diverse cis-acting elements and trans-acting factors. Alternative splicing events of oncogenes, tumor suppressor genes and metastasis suppressor genes are associated with the initiation and development of human neoplasms. The protein isoforms sourced from alternative splicing take part in regulating the gene transcription, cell cycle, apoptosis of cells, and playing a role in tumor growth. It is possible for molecular therapy to target directly isoforms of protein produced by alternative splicing or to interfere with the process of alternative splicing.
前体mRNA的可变剪接是在转录后水平调控基因功能以及在高等真核生物中产生蛋白质组多样性的重要机制。可变剪接受多种顺式作用元件和反式作用因子之间相互作用的调控。癌基因、肿瘤抑制基因和转移抑制基因的可变剪接事件与人类肿瘤的发生和发展相关。源自可变剪接的蛋白质异构体参与调节基因转录、细胞周期、细胞凋亡,并在肿瘤生长中发挥作用。分子疗法有可能直接靶向由可变剪接产生的蛋白质异构体,或干扰可变剪接过程。